A80.2HCl interacts with CRBN and MYC, inducing MYC degradation at nanomolar concentrations, re-establishing the sensitivity of MYC-overexpressing cancer cells to CDK4/6 inhibitors [162] and indicating the potential role of virtual screening for small-molecule degraders. Here, MYC is linked to cancer.